Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

Rare and Genetic Kidney Disease Drug Development Summit

Evvnt Promotion / evvnt
Archivio
-
30.11.2021 - 02.12.2021  Online
Time: 10:00 am - 5:30 pm
 
Temi della conferenza
Marrying unmissable insights from global renal experts, the 1st Rare and Genetic Kidney Disease Drug Development Summit is uniquely positioned to provide you with transformative perspectives from identifying genetic drivers of rare kidney diseases to innovative trial design in small disease populations to accelerate progress of your genetic kidney disease pipeline.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/853526-3?pid=4832

Speakers: Alan Glicklich, Chief Medical Officer, Chinook Therapeutics, Alex Bell, Director Kidney Disease Drug Discovery, Ionis Pharmaceuticals and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/853526-1?pid=4832
Ms. Emily Birt
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 1899.00 - USD 3397.00
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioEuropean Health Forum GasteinAlumni Club Medizinische Universität WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Center of ExcellencenewTreeAnästhesie in Entwicklungsländern e. V.Österreichische Akademie der Ärzte